IMMODULON, LEADERS IN IMMUNO-ONCOLOGY Immodulon Therapeutics Ltd. is a privately-owned clinical-stage immuno-oncology company primarily focused on the development of safe, effective and novel treatments for cancer. Its lead drug candidate, IMM-101, has shown promise in early clinical trials, demonstrating potential for the platform. IMM-101 has a unique mechanism of action that should not only make this innovative product applicable to a large range of cancers but, in combination with immune checkpoint inhibitors and other standard-of-care treatments, is expected to enhance their efficacy without increasing the safety burden for the patient.
View Top Employees from Immodulon Therapeutics Limited| Website | http://www.immodulon.com/ |
| Revenue | $6 million |
| Employees | 10 (4 on RocketReach) |
| Phone | +44 20 3137 6346 |
| Fax | +44 20 8929 9283 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Therapeutics, Health Care |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Immodulon Therapeutics Limited employee's phone or email?
Immodulon Therapeutics Limited Questions
The Immodulon Therapeutics Limited annual revenue was $6 million in 2023.
4 people are employed at Immodulon Therapeutics Limited.
The NAICS codes for Immodulon Therapeutics Limited are [54, 54171, 541714, 541, 5417].
The SIC codes for Immodulon Therapeutics Limited are [873, 87].
Top Immodulon Therapeutics Limited Employees
-
22
-
ViewMaikel Dijkstal
CMC Programme Manager at Immodulon Therapeutics Limited
Almere, Flevoland, Netherlands1 -
ViewIlda Guimarey
Company Secretary and Office Manager at Immodulon Therapeutics Limited
London, Greater London, United Kingdom1
Related Companies
